nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—ESR2—atherosclerosis	0.552	0.619	CbGaD
Trilostane—ESR1—atherosclerosis	0.34	0.381	CbGaD
Trilostane—Danazol—CCL2—atherosclerosis	0.00147	0.395	CrCbGaD
Trilostane—Danazol—ESR1—atherosclerosis	0.000564	0.152	CrCbGaD
Trilostane—Estradiol—ESR2—atherosclerosis	0.000559	0.151	CrCbGaD
Trilostane—Estradiol—ESR1—atherosclerosis	0.000344	0.0927	CrCbGaD
Trilostane—Progesterone—ESR1—atherosclerosis	0.000292	0.0787	CrCbGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000227	0.00219	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000226	0.00218	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP7A1—atherosclerosis	0.000225	0.00217	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000224	0.00216	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—NOS2—atherosclerosis	0.000224	0.00216	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000224	0.00216	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ALOX5—atherosclerosis	0.000221	0.00213	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—AKT1—atherosclerosis	0.00022	0.00212	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000217	0.00209	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000214	0.00207	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—AGT—atherosclerosis	0.000214	0.00206	CbGpPWpGaD
Trilostane—Methyltestosterone—ALB—atherosclerosis	0.000212	0.0571	CrCbGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000211	0.00203	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP27A1—atherosclerosis	0.000208	0.002	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—INS—atherosclerosis	0.000205	0.00198	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000205	0.00197	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000204	0.00197	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000201	0.00194	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.0002	0.00192	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—LEP—atherosclerosis	0.000199	0.00191	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NAMPT—atherosclerosis	0.000198	0.00191	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000197	0.0019	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOA2—atherosclerosis	0.000197	0.0019	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ALOX5AP—atherosclerosis	0.000197	0.0019	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—LIPC—atherosclerosis	0.000197	0.0019	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ALOX15—atherosclerosis	0.000197	0.0019	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PLA2G2A—atherosclerosis	0.000197	0.0019	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOC3—atherosclerosis	0.000196	0.00189	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000195	0.00188	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—LDLR—atherosclerosis	0.000195	0.00188	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ABCG5—atherosclerosis	0.000195	0.00188	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000195	0.00187	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—HMGCR—atherosclerosis	0.000193	0.00186	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—MMP9—atherosclerosis	0.000193	0.00186	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MMP2—atherosclerosis	0.000192	0.00185	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CETP—atherosclerosis	0.00019	0.00183	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LPA—atherosclerosis	0.000188	0.00181	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—BGN—atherosclerosis	0.000182	0.00175	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SCARB1—atherosclerosis	0.000182	0.00175	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000181	0.00174	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOA5—atherosclerosis	0.00018	0.00174	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000178	0.00171	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000177	0.00171	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000176	0.0017	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—AKT1—atherosclerosis	0.000176	0.0017	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000175	0.00169	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000175	0.00168	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PLA2G1B—atherosclerosis	0.000174	0.00167	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HMGCR—atherosclerosis	0.000172	0.00166	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IFNG—atherosclerosis	0.000172	0.00166	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000172	0.00165	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.00017	0.00164	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.00017	0.00163	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ALOX5—atherosclerosis	0.000168	0.00162	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CXCL8—atherosclerosis	0.00016	0.00154	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000158	0.00153	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000155	0.00149	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000155	0.00149	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000154	0.00148	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PARP1—atherosclerosis	0.000154	0.00148	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IFNG—atherosclerosis	0.000153	0.00148	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ABCA1—atherosclerosis	0.000153	0.00148	CbGpPWpGaD
Trilostane—Estradiol—ALB—atherosclerosis	0.000153	0.0413	CrCbGaD
Trilostane—HSD3B2—Metabolism—NAMPT—atherosclerosis	0.00015	0.00145	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IFNG—atherosclerosis	0.00015	0.00144	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.00015	0.00144	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LIPC—atherosclerosis	0.000149	0.00144	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—NOS3—atherosclerosis	0.000149	0.00143	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOC3—atherosclerosis	0.000149	0.00143	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000148	0.00143	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LDLR—atherosclerosis	0.000148	0.00142	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000146	0.00141	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000146	0.0014	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CETP—atherosclerosis	0.000144	0.00139	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000144	0.00139	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MAPK8—atherosclerosis	0.000141	0.00135	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.00014	0.00135	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000139	0.00134	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SCARB1—atherosclerosis	0.000138	0.00133	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000136	0.00131	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000134	0.00129	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HMOX1—atherosclerosis	0.000132	0.00127	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HMGCR—atherosclerosis	0.00013	0.00126	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.00013	0.00126	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000128	0.00123	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—NFKB1—atherosclerosis	0.000128	0.00123	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—IL1B—atherosclerosis	0.000127	0.00122	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000126	0.00121	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOB—atherosclerosis	0.000126	0.00121	CbGpPWpGaD
Trilostane—Testosterone—ALB—atherosclerosis	0.000123	0.0331	CrCbGaD
Trilostane—ESR1—ATF-2 transcription factor network—MAPK3—atherosclerosis	0.000123	0.00118	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GSTM1—atherosclerosis	0.000123	0.00118	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—LPL—atherosclerosis	0.00012	0.00116	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000119	0.00115	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000118	0.00114	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—NFKB1—atherosclerosis	0.000118	0.00114	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PDGFB—atherosclerosis	0.000118	0.00114	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000118	0.00113	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GPX1—atherosclerosis	0.000117	0.00113	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000117	0.00113	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ABCA1—atherosclerosis	0.000116	0.00112	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MAPK8—atherosclerosis	0.000116	0.00112	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CD36—atherosclerosis	0.000114	0.0011	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000111	0.00107	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—atherosclerosis	0.000111	0.00107	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MAPK3—atherosclerosis	0.00011	0.00106	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000109	0.00105	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—atherosclerosis	0.000108	0.00104	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—TGFB1—atherosclerosis	0.000106	0.00102	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARA—atherosclerosis	0.000106	0.00102	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000106	0.00102	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—STAT3—atherosclerosis	0.000106	0.00102	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000104	0.001	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AGT—atherosclerosis	0.000103	0.000992	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000101	0.000977	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MAPK3—atherosclerosis	0.000101	0.000976	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOE—atherosclerosis	0.000101	0.000972	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000101	0.000969	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CAV1—atherosclerosis	9.99e-05	0.000963	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HMOX1—atherosclerosis	9.97e-05	0.00096	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOA1—atherosclerosis	9.97e-05	0.00096	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARA—atherosclerosis	9.76e-05	0.00094	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOB—atherosclerosis	9.55e-05	0.00092	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	9.52e-05	0.000917	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GSTM1—atherosclerosis	9.29e-05	0.000895	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	9.23e-05	0.000889	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LPL—atherosclerosis	9.12e-05	0.000878	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3CG—atherosclerosis	9.1e-05	0.000877	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—atherosclerosis	8.98e-05	0.000865	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GPX1—atherosclerosis	8.9e-05	0.000857	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—ESR1—atherosclerosis	8.84e-05	0.000852	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARG—atherosclerosis	8.79e-05	0.000846	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CD36—atherosclerosis	8.66e-05	0.000835	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	8.62e-05	0.000831	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—INS—atherosclerosis	8.62e-05	0.00083	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—HSPA1B—atherosclerosis	8.31e-05	0.000801	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—atherosclerosis	8.21e-05	0.000791	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—atherosclerosis	8.18e-05	0.000788	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARG—atherosclerosis	8.06e-05	0.000777	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARA—atherosclerosis	8.06e-05	0.000776	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ALB—atherosclerosis	7.9e-05	0.000761	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—atherosclerosis	7.83e-05	0.000754	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AGT—atherosclerosis	7.8e-05	0.000752	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	7.77e-05	0.000748	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PARP1—atherosclerosis	7.76e-05	0.000748	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOE—atherosclerosis	7.64e-05	0.000736	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CAV1—atherosclerosis	7.57e-05	0.00073	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NOS3—atherosclerosis	7.56e-05	0.000728	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOA1—atherosclerosis	7.56e-05	0.000728	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PARP1—atherosclerosis	7.41e-05	0.000714	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—atherosclerosis	7.39e-05	0.000712	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—ESR2—atherosclerosis	7.35e-05	0.000708	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—SERPINE1—atherosclerosis	7.27e-05	0.0007	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTGS2—atherosclerosis	6.91e-05	0.000666	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3CG—atherosclerosis	6.9e-05	0.000665	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—atherosclerosis	6.84e-05	0.000659	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	6.75e-05	0.00065	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARG—atherosclerosis	6.66e-05	0.000641	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—INS—atherosclerosis	6.53e-05	0.000629	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	6.44e-05	0.00062	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	6.43e-05	0.000619	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.42e-05	0.000618	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	6.12e-05	0.00059	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ALB—atherosclerosis	5.99e-05	0.000577	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—MAPK3—atherosclerosis	5.76e-05	0.000555	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NOS3—atherosclerosis	5.73e-05	0.000552	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SIRT1—atherosclerosis	5.65e-05	0.000544	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.59e-05	0.000538	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HRH1—atherosclerosis	5.58e-05	0.000538	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.49e-05	0.000529	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTGS2—atherosclerosis	5.24e-05	0.000505	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	5.07e-05	0.000489	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARA—atherosclerosis	4.92e-05	0.000474	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.8e-05	0.000462	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARA—atherosclerosis	4.7e-05	0.000453	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.66e-05	0.000449	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOA4—atherosclerosis	4.38e-05	0.000422	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.35e-05	0.000419	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ESR1—atherosclerosis	4.26e-05	0.00041	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—atherosclerosis	4.21e-05	0.000406	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—HSPA1B—atherosclerosis	4.19e-05	0.000404	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARG—atherosclerosis	4.07e-05	0.000392	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL4—atherosclerosis	4.04e-05	0.000389	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	3.91e-05	0.000376	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—atherosclerosis	3.89e-05	0.000374	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARG—atherosclerosis	3.88e-05	0.000374	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOA2—atherosclerosis	3.77e-05	0.000363	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PARP1—atherosclerosis	3.74e-05	0.00036	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—SERPINE1—atherosclerosis	3.66e-05	0.000353	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—UTS2—atherosclerosis	3.6e-05	0.000346	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ESR2—atherosclerosis	3.54e-05	0.000341	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SERPINE1—atherosclerosis	3.5e-05	0.000337	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—atherosclerosis	3.47e-05	0.000335	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CX3CR1—atherosclerosis	3.45e-05	0.000332	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CASR—atherosclerosis	3.45e-05	0.000332	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CX3CL1—atherosclerosis	3.38e-05	0.000326	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.24e-05	0.000312	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CNR2—atherosclerosis	3.21e-05	0.000309	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VWF—atherosclerosis	2.86e-05	0.000275	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SIRT1—atherosclerosis	2.85e-05	0.000274	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOC3—atherosclerosis	2.84e-05	0.000274	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LDLR—atherosclerosis	2.82e-05	0.000272	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL3—atherosclerosis	2.76e-05	0.000266	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NCF1—atherosclerosis	2.64e-05	0.000254	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—atherosclerosis	2.63e-05	0.000254	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EDNRA—atherosclerosis	2.49e-05	0.00024	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR2—atherosclerosis	2.49e-05	0.00024	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CYBA—atherosclerosis	2.48e-05	0.000239	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PLAT—atherosclerosis	2.43e-05	0.000234	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GHRL—atherosclerosis	2.43e-05	0.000234	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PARP1—atherosclerosis	2.43e-05	0.000234	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARA—atherosclerosis	2.37e-05	0.000228	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—MAPK3—atherosclerosis	2.28e-05	0.000219	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KNG1—atherosclerosis	2.13e-05	0.000205	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AGTR1—atherosclerosis	2.12e-05	0.000204	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PLG—atherosclerosis	2.07e-05	0.000199	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARG—atherosclerosis	1.96e-05	0.000189	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SOCS3—atherosclerosis	1.96e-05	0.000188	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MMP3—atherosclerosis	1.89e-05	0.000182	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF2—atherosclerosis	1.88e-05	0.000181	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOB—atherosclerosis	1.83e-05	0.000176	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EDN1—atherosclerosis	1.8e-05	0.000173	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL5—atherosclerosis	1.78e-05	0.000172	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SERPINE1—atherosclerosis	1.76e-05	0.00017	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LPL—atherosclerosis	1.74e-05	0.000168	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRKCG—atherosclerosis	1.7e-05	0.000163	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SPP1—atherosclerosis	1.65e-05	0.000159	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—atherosclerosis	1.54e-05	0.000148	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PDGFB—atherosclerosis	1.53e-05	0.000147	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AGT—atherosclerosis	1.49e-05	0.000144	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOE—atherosclerosis	1.46e-05	0.000141	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LEP—atherosclerosis	1.46e-05	0.000141	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CAV1—atherosclerosis	1.45e-05	0.000139	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOA1—atherosclerosis	1.44e-05	0.000139	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—F2—atherosclerosis	1.38e-05	0.000133	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	1.32e-05	0.000127	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INS—atherosclerosis	1.25e-05	0.00012	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL2—atherosclerosis	1.23e-05	0.000118	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1—atherosclerosis	1.21e-05	0.000116	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—MAPK3—atherosclerosis	1.15e-05	0.000111	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	1.15e-05	0.00011	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NOS3—atherosclerosis	1.09e-05	0.000105	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL8—atherosclerosis	9.71e-06	9.36e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MMP9—atherosclerosis	8.78e-06	8.46e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NFKB1—atherosclerosis	8.69e-06	8.37e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAPK8—atherosclerosis	8.54e-06	8.23e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VEGFA—atherosclerosis	7.89e-06	7.6e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—STAT3—atherosclerosis	7.81e-06	7.52e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—atherosclerosis	7.74e-06	7.46e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAPK3—atherosclerosis	7.46e-06	7.19e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TGFB1—atherosclerosis	7.24e-06	6.97e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—atherosclerosis	5.46e-06	5.26e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—atherosclerosis	5.03e-06	4.85e-05	CbGpPWpGaD
